| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |